Total Payments
$1,682
2023 Payments
$367.31
Companies
18
Transactions
99
Medicare Patients
3,340
Medicare Billing
$202,101
Payment Breakdown by Category
Food & Beverage$1,643 (97.7%)
Education$39.36 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,643 | 96 | 97.7% |
| Education | $39.36 | 3 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $653.91 | 38 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $473.47 | 29 | $0 (2023) |
| Insmed, Inc. | $114.27 | 8 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $88.85 | 5 | $0 (2022) |
| Inogen, Inc. | $46.89 | 3 | $0 (2022) |
| Axsome Therapeutics, Inc. | $44.68 | 2 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $34.75 | 1 | $0 (2023) |
| Baxter Healthcare | $33.97 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $31.83 | 2 | $0 (2022) |
| Mylan Specialty L.P. | $27.40 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $367.31 | 19 | GlaxoSmithKline, LLC. ($123.43) |
| 2022 | $358.08 | 23 | GlaxoSmithKline, LLC. ($163.11) |
| 2021 | $402.31 | 24 | AstraZeneca Pharmaceuticals LP ($113.79) |
| 2020 | $554.31 | 33 | GlaxoSmithKline, LLC. ($278.23) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Respiratory | ||||||
| 11/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Neurology | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Respiratory | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Neurology | ||||||
| 08/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: Cardiology | ||||||
| 07/13/2023 | Baxter Healthcare | Hillrom - Volara System (Device) | Food and Beverage | In-kind items and services | $33.97 | General |
| Category: Airway Clearance Device | ||||||
| 07/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Respiratory | ||||||
| 06/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.57 | General |
| 04/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Respiratory | ||||||
| 02/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.26 | General |
| 01/04/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: RESPIRATORY | ||||||
| 01/03/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Respiratory | ||||||
| 12/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: INSOMNIA | ||||||
| 11/29/2022 | Inogen, Inc. | InogenOne (Device) | Food and Beverage | Cash or cash equivalent | $1.75 | General |
| Category: Oxygen Concentrator | ||||||
| 11/10/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 636 | 706 | $59,839 | $35,242 |
| 2022 | 6 | 714 | 813 | $59,590 | $34,727 |
| 2021 | 7 | 845 | 970 | $80,482 | $55,253 |
| 2020 | 11 | 1,145 | 1,407 | $132,951 | $76,879 |
Total Patients
3,340
Total Services
3,896
Medicare Billing
$202,101
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 170 | $23,940 | $14,769 | 61.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 150 | 168 | $18,560 | $10,197 | 54.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $5,602 | $3,281 | 58.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 53 | 53 | $3,065 | $2,012 | 65.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 53 | 53 | $2,267 | $1,608 | 70.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 51 | 52 | $1,885 | $983.50 | 52.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 30 | 30 | $1,380 | $801.53 | 58.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 17 | $955.12 | $619.31 | 64.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 39 | 39 | $683.28 | $341.51 | 50.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 44 | 45 | $819.90 | $294.12 | 35.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 29 | 29 | $522.00 | $221.48 | 42.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 18 | 19 | $159.79 | $113.22 | 70.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 177 | $24,225 | $14,887 | 61.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 184 | 213 | $23,430 | $13,183 | 56.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 134 | 145 | $5,075 | $2,686 | 52.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 29 | 29 | $1,623 | $1,090 | 67.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 29 | 29 | $1,217 | $825.11 | 67.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 62 | 68 | $1,191 | $628.24 | 52.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 62 | 68 | $1,239 | $460.70 | 37.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 16 | 16 | $704.00 | $455.74 | 64.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 52 | 56 | $780.00 | $435.95 | 55.9% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 12 | 12 | $105.69 | $76.97 | 72.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 302 | 368 | $35,493 | $22,693 | 63.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 189 | $24,790 | $17,962 | 72.5% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 120 | 123 | $7,139 | $5,238 | 73.4% |
About Dr. Robert Burnaugh, MD
Dr. Robert Burnaugh, MD is a Pulmonary Disease healthcare provider based in Hilton Head, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699743260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Burnaugh, MD has received a total of $1,682 in payments from pharmaceutical and medical device companies, with $367.31 received in 2023. These payments were reported across 99 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,643).
As a Medicare-enrolled provider, Burnaugh has provided services to 3,340 Medicare beneficiaries, totaling 3,896 services with total Medicare billing of $202,101. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Hilton Head, SC
- Active Since 03/09/2006
- Last Updated 05/10/2016
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1699743260
Products in Payments
- TRELEGY ELLIPTA (Drug) $473.09
- BREZTRI (Drug) $134.50
- SYMBICORT (Drug) $115.30
- ANORO ELLIPTA (Drug) $111.98
- Arikayce (Drug) $98.03
- NUCALA (Biological) $68.84
- STIOLTO RESPIMAT (Drug) $50.81
- FASENRA (Biological) $49.44
- InogenOne (Device) $46.89
- Sunosi (Drug) $44.68
- OFEV (Drug) $38.04
- BREZTRI AEROSPHERE (Drug) $38.02
- OPSUMIT (Drug) $34.75
- Hillrom - Volara System (Device) $33.97
- DUPIXENT (Biological) $31.83
- TEZSPIRE (Biological) $31.74
- TAGRISSO (Drug) $29.08
- Yupelri (Drug) $27.40
- SUNOSI (Drug) $22.98
- FARXIGA (Drug) $19.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.